JLL Brokers Sale of Singing River Cancer Center in Alabama for Cypress West Partners to Remedy Medical Properties, Kayne Anderson Real Estate

FLORENCE, Ala. — July 22, 2026 — JLL has completed the sale of Singing River Cancer Center, a 45,904-square-foot, purpose-built cancer center in Florence, Alabama. Cypress West Partners sold the property to a joint venture between Remedy Medical Properties and Kayne Anderson Real Estate, JLL announced.

Property Overview: A Purpose-Built Oncology Facility in the Tennessee Valley

Constructed in 2020, Singing River Cancer Center is a single-story integrated cancer center situated on 6.55 acres at 180 Cox Creek Parkway South in the Shoals region of North Alabama. The facility is operated by OneOncology affiliates and provides medical oncology, diagnostic imaging, chemotherapy, radiation oncology, and infusion services to more than 150,000 residents across the Tennessee Valley.

The property's location places it within approximately two hours of Nashville, Memphis, Birmingham, and Huntsville, broadening its patient and referral reach across a multi-city trade area. The site is also in proximity to the University of North Alabama and multiple local and regional hospitals.

Transaction Details: JLL's Medical Properties Group Advises Cypress West Partners

JLL Capital Markets' Medical Properties Group represented the seller, Cypress West Partners, and procured the buyer. The JLL team was led by Senior Managing Directors Evan Kovac, Andrew Milne, and John Chun, along with Senior Director Matt DiCesare and Managing Director Timothy Joyce.

"Singing River Cancer Center represents the type of specialized healthcare asset that continues to attract strong investor interest in today's market," said Kovac. "The property's strategic location in the Tennessee Valley, combined with its modern infrastructure and established tenant base serving a significant regional population, made it a compelling investment opportunity. Purpose-built cancer centers like this one fill a critical need in their communities while offering investors quality real estate with long-term operational stability."

The sale price, cap rate, and financing terms were not disclosed in the announcement.

Buyer Profile: Remedy Medical Properties and Kayne Anderson Real Estate

The acquiring joint venture brings together two established players in healthcare real estate. Remedy Medical Properties is the largest owner and operator of outpatient medical real estate in the United States, with more than 52.4 million square feet across more than 1,100 properties in 44 states. The company offers a vertically integrated platform encompassing investments, asset management, development, leasing, property management, and consulting.

Kayne Anderson Real Estate is the joint venture's equity partner on the buyer side.

Seller Background: Cypress West Partners

Cypress West Partners is a vertically integrated owner-operator focused on acquiring, developing, and operating healthcare real estate across the United States. The firm is based in Orange County, California, and Dallas, Texas, and is led by founders Chris Cumella and Jeff Johnson, along with principals Eric Minor, Ed Hernandez, and Sam Clark.

Market Context: Specialized Healthcare Assets Draw Investor Capital

The Singing River transaction reflects broader investor interest in outpatient and oncology-focused real estate. Cancer centers are widely viewed as service-intensive, mission-critical properties with demand characteristics that can be less cyclical than general office or retail real estate. Purpose-built facilities with established clinical operators and large regional patient populations have increasingly drawn institutional capital seeking long-term tenancy stability.

JLL Capital Markets operates as a full-service global provider of capital solutions for real estate investors and occupiers, with more than 3,000 Capital Markets specialists worldwide and offices in nearly 50 countries. JLL (NYSE: JLL) reported annual revenue of $26.1 billion and operates in more than 80 countries as of March 31, 2026.

Sources

JLL Newsroom — OneOncology Cancer Center in North Alabama Sold (July 22, 2026)